NASDAQ:NYXH Nyxoah (NYXH) Stock Forecast, Price & News $7.05 -0.07 (-0.98%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$6.68▼$7.4950-Day Range$7.05▼$8.2652-Week Range$4.36▼$10.34Volume6,775 shsAverage Volume1,991 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$13.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Nyxoah MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside84.4% Upside$13.00 Price TargetShort InterestBearish0.94% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.27Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.92) to ($1.76) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.79 out of 5 stars 3.4 Analyst's Opinion Consensus RatingNyxoah has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.00, Nyxoah has a forecasted upside of 84.4% from its current price of $7.05.Amount of Analyst CoverageNyxoah has only been the subject of 4 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted0.94% of the float of Nyxoah has been sold short.Short Interest Ratio / Days to CoverNyxoah has a short interest ratio ("days to cover") of 41.2, which indicates bearish sentiment.Change versus previous monthShort interest in Nyxoah has recently decreased by 2.74%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldNyxoah does not currently pay a dividend.Dividend GrowthNyxoah does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NYXH. Previous Next 1.8 News and Social Media Coverage News SentimentNyxoah has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Nyxoah this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nyxoah insiders have not sold or bought any company stock.Percentage Held by Insiders17.11% of the stock of Nyxoah is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Nyxoah are expected to grow in the coming year, from ($1.92) to ($1.76) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nyxoah is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nyxoah is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNyxoah has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Nyxoah (NASDAQ:NYXH) StockNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.Read More NYXH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NYXH Stock News HeadlinesOctober 1, 2023 | markets.businessinsider.comKepler Capital Keeps Their Buy Rating on Nyxoah (NYXH)September 29, 2023 | markets.businessinsider.comBuy Rating on Nyxoah Amid Potential Market Expansion through ResMed Partnership and Genio Sales ProspectOctober 1, 2023 | Legacy Research (Ad)Elon Did It Again: This Could be Bigger than TeslaLove him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.September 27, 2023 | americanbankingnews.comNyxoah (NASDAQ:NYXH) Given Overweight Rating at Cantor FitzgeraldSeptember 22, 2023 | americanbankingnews.comHead-To-Head Survey: Nyxoah (NASDAQ:NYXH) & Vivos (OTCMKTS:RDGL)September 12, 2023 | finance.yahoo.comNyxoah to Participate in the Cantor Fitzgerald Global Healthcare ConferenceSeptember 5, 2023 | finance.yahoo.comNyxoah to Participate in Upcoming Investor ConferencesAugust 11, 2023 | markets.businessinsider.comKepler Capital Sticks to Their Buy Rating for Nyxoah (NYXH)October 1, 2023 | Legacy Research (Ad)Elon Did It Again: This Could be Bigger than TeslaLove him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.August 9, 2023 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Nyxoah (NYXH)August 8, 2023 | finance.yahoo.comNyxoah SA (NYXH) Reports Q2 Loss, Tops Revenue EstimatesAugust 8, 2023 | finance.yahoo.comNyxoah Reports Second Quarter and First Half 2023 Financial and Operating ResultsJuly 31, 2023 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About NyxoahJuly 28, 2023 | finanznachrichten.deNyxoah: Publication Relating to a Transparency NotificationJuly 28, 2023 | finance.yahoo.comNyxoah to Participate in the 43rd Canaccord Genuity Growth ConferenceJuly 28, 2023 | finance.yahoo.comNyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023May 30, 2023 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Nyxoah (NYXH)May 18, 2023 | msn.com4 Analysts Have This to Say About NyxoahMay 17, 2023 | finance.yahoo.comNyxoah S.A. (NASDAQ:NYXH) Q1 2023 Earnings Call TranscriptMay 16, 2023 | finance.yahoo.comNyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue EstimatesMay 16, 2023 | finance.yahoo.comNyxoah Reports First Quarter 2023 Financial and Operating ResultsMay 15, 2023 | msn.comEarnings Preview: NyxoahMay 12, 2023 | finance.yahoo.comInvitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023May 11, 2023 | msn.comNyxoah (BRU:NYXH) Price Target Increased by 16.04% to 18.94May 10, 2023 | finance.yahoo.comNyxoah Appoints Christoph Eigenmann as Chief Commercial OfficerMay 1, 2023 | finance.yahoo.comNyxoah to Release First Quarter 2023 Financial Results on May 16, 2023April 27, 2023 | markets.businessinsider.comNyxoah (NYXH) Receives a Buy from Kepler CapitalSee More Headlines Receive NYXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter. Email Address NYXH Company Calendar Last Earnings8/08/2023Today10/01/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NYXH CUSIPN/A CIK1857190 Webwww.nyxoah.com Phone321-022-2355Fax321-045-9075Employees137Year FoundedN/APrice Target and Rating Average Stock Price Forecast$13.00 High Stock Price Forecast$15.00 Low Stock Price Forecast$11.00 Forecasted Upside/Downside+84.4%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,900,000.00 Net Margins-1,457.29% Pretax Margin-1,399.16% Return on Equity-35.76% Return on Assets-29.27% Debt Debt-to-Equity Ratio0.10 Current Ratio5.99 Quick Ratio5.92 Sales & Book Value Annual Sales$3.25 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$5.08 per share Price / Book1.39Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.44 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Robert Taub MBA (Age 76)Co-Founder & Chairman Comp: $82.28kMr. Olivier Taelman (Age 51)CEO & Exec. Director Comp: $673.6kMr. Loic Moreau (Age 43)Chief Financial Officer Comp: $338.34kMr. Bruno OnkelinxChief Technology OfficerMikaela KirkwoodCorp. Communication & Investor Relations Mang.Ms. An MoonenGen. CounselMr. Remi RenardVP of Market & Market AccessMs. Inge VanwittenberghGlobal Human Resource DirectorMr. David M. DeMartinoChief Strategy OfficerMr. Christoph EigenmannChief Commercial OfficerMore ExecutivesKey Competitors60 Degrees Pharmaceuticals, Inc. WarrantNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWAlvotechNASDAQ:ALVOWView All CompetitorsInstitutional OwnershipGoldman Sachs Group Inc.Sold 99,360 shares on 8/15/2023Ownership: 0.234%Pura Vida Investments LLCSold 16,314 shares on 8/14/2023Ownership: 0.000%ExodusPoint Capital Management LPBought 5,787 shares on 8/11/2023Ownership: 0.000%View All Institutional Transactions NYXH Stock - Frequently Asked Questions Should I buy or sell Nyxoah stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nyxoah in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NYXH shares. View NYXH analyst ratings or view top-rated stocks. What is Nyxoah's stock price forecast for 2023? 5 equities research analysts have issued 12-month price targets for Nyxoah's shares. Their NYXH share price forecasts range from $11.00 to $15.00. On average, they predict the company's share price to reach $13.00 in the next year. This suggests a possible upside of 84.4% from the stock's current price. View analysts price targets for NYXH or view top-rated stocks among Wall Street analysts. How have NYXH shares performed in 2023? Nyxoah's stock was trading at $4.99 at the beginning of the year. Since then, NYXH shares have increased by 41.3% and is now trading at $7.05. View the best growth stocks for 2023 here. When is Nyxoah's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our NYXH earnings forecast. How were Nyxoah's earnings last quarter? Nyxoah S.A. (NASDAQ:NYXH) announced its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.45) by $0.04. The business earned $1.21 million during the quarter, compared to the consensus estimate of $1.04 million. Nyxoah had a negative net margin of 1,457.29% and a negative trailing twelve-month return on equity of 35.76%. When did Nyxoah IPO? (NYXH) raised $83 million in an IPO on Friday, July 2nd 2021. The company issued 2,760,000 shares at a price of $30.00 per share. What is Nyxoah's stock symbol? Nyxoah trades on the NASDAQ under the ticker symbol "NYXH." How do I buy shares of Nyxoah? Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Nyxoah's stock price today? One share of NYXH stock can currently be purchased for approximately $7.05. How many employees does Nyxoah have? The company employs 137 workers across the globe. How can I contact Nyxoah? The official website for the company is www.nyxoah.com. The company can be reached via phone at 321-022-2355, via email at ir@nyxoah.com, or via fax at 321-045-9075. This page (NASDAQ:NYXH) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.